Research & Development



  “前幾天王淼淼給我發了一份你們的課表。”林徵羽依舊閉著眼。   一邊說著,一邊就著手腕把陸昔年一下子拉過去,抱在懷里,下巴蹭了蹭陸昔年軟軟的發頂。av资源   青蛙王子︰有沒有覺得Lin長得和我的id特別相得益彰?[愉快][喜聞樂見]av在线   雲瑯苦笑起來,這些狼的目標是昨日出現的那些野豬,自己充當了人家狩獵的誘餌。   Lin 使用M416自動□□淘汰了 yan。好了AV第四色016   不帶這麼突然襲擊的!一心想撩人反被撩的陸昔年欲哭無淚,此時此刻完全沒心思看電影了,目光時不時落在林徵羽的側臉上。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo